Strengths and caveats of identifying resistance genes from whole genome sequencing data.
Journal:
Expert review of anti-infective therapy
Published Date:
Dec 16, 2021
Abstract
INTRODUCTION: Antimicrobial resistance (AMR) continues to present major challenges to modern healthcare. Recent advances in whole-genome sequencing (WGS) have made the rapid molecular characterization of AMR a realistic possibility for diagnostic laboratories; yet major barriers to clinical implementation exist.